Inpatient Stroke Service Rotation
... be succinctly completed, accurate, understandable, and dictated within 24 hours of the discharge. If the patient does not have a PCP, it is the responsibility of the HO-2 to make arrangements for primary care follow-up and clearly document this. ...
... be succinctly completed, accurate, understandable, and dictated within 24 hours of the discharge. If the patient does not have a PCP, it is the responsibility of the HO-2 to make arrangements for primary care follow-up and clearly document this. ...
Guideline on clinical investigation of medicinal products
... complications, reduction in hospital readmissions and mortality. The relative order, importance and application of particular interventions are determined by aetiology and clinical presentation which in turn impact the design of the studies used to evaluate drugs for AHF (or AHFS) including patient ...
... complications, reduction in hospital readmissions and mortality. The relative order, importance and application of particular interventions are determined by aetiology and clinical presentation which in turn impact the design of the studies used to evaluate drugs for AHF (or AHFS) including patient ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
... developing countries depends primarily upon herbal medicine for basic health care.[1]The traditional systems of medicine, commonly referred to as ‘Complementary and Alternative Medicine’ (CAM) are widely used and looked upon for possible and safe solutions to present day health and medical problems ...
... developing countries depends primarily upon herbal medicine for basic health care.[1]The traditional systems of medicine, commonly referred to as ‘Complementary and Alternative Medicine’ (CAM) are widely used and looked upon for possible and safe solutions to present day health and medical problems ...
Conventional glucocorticoid replacement overtreats adult
... controls. We have also shown that low-dose hydrocortisone therapy produces a cortisol profile similar to that of healthy controls. Our results suggest that current conventional hydrocortisone replacement doses are supraphysiological for patients with partial ACTH deficiency, and a further appraisal ...
... controls. We have also shown that low-dose hydrocortisone therapy produces a cortisol profile similar to that of healthy controls. Our results suggest that current conventional hydrocortisone replacement doses are supraphysiological for patients with partial ACTH deficiency, and a further appraisal ...
COPD: Management of Acute Exacerbations and Chronic Stable
... Twice-daily dosing is an added benefit and may be convenient for many patients. Orally administered beta2 agonists have more side effects than inhaled forms. Hence, oral agents generally are not used to treat exacerbations of COPD. ANTICHOLINERGICS ...
... Twice-daily dosing is an added benefit and may be convenient for many patients. Orally administered beta2 agonists have more side effects than inhaled forms. Hence, oral agents generally are not used to treat exacerbations of COPD. ANTICHOLINERGICS ...
Spotlight Cardiology This month December 2007
... temporary and permanent disability in 1990; for the year 2020, it is projected to be second only to ischaemic heart disease as a cause of illness burden worldwide. Depression can also increase the morbidity of physical illness. Among middle-aged women, the presence of depression increases the adjust ...
... temporary and permanent disability in 1990; for the year 2020, it is projected to be second only to ischaemic heart disease as a cause of illness burden worldwide. Depression can also increase the morbidity of physical illness. Among middle-aged women, the presence of depression increases the adjust ...
Cyclosporine: the silver bullet
... Cyclosporine is a macrolide derived from a fungus. Cyclosporine was first used to treat psoriasis in 1979 and finally approved in 1983. Other drugs in this family include tacrolimus (ProtopicR introduced in 2000) and pimecrolimus (ElidelR introduced in 2001). Cyclosporine drugs work by targeting the ...
... Cyclosporine is a macrolide derived from a fungus. Cyclosporine was first used to treat psoriasis in 1979 and finally approved in 1983. Other drugs in this family include tacrolimus (ProtopicR introduced in 2000) and pimecrolimus (ElidelR introduced in 2001). Cyclosporine drugs work by targeting the ...
THE IMPACT OF OPERATIVE FLUIDS ON THE PREVENTION OF POSTOPERATIVE AMBULATORY SURGERY
... have been done on the prevention of nausea and vomiting and different regimens have been suggested2,4-11. However, only limited work had been done to determine the correlation between preoperative fluid therapy and the well being of patients in the postoperative period. Cook et al. reported decrease ...
... have been done on the prevention of nausea and vomiting and different regimens have been suggested2,4-11. However, only limited work had been done to determine the correlation between preoperative fluid therapy and the well being of patients in the postoperative period. Cook et al. reported decrease ...
CYP2C19 Genotyping - Beaumont Laboratory
... CYP2C19 genotyping Know your patient’s response to clopidogrel before prescribing Clopidogrel decreases the likelihood of future atherothrombotic events Clopidogrel is an anti-platelet medication that requires activation by the isoenzyme Cytochrome P450 2C19. Roughly 40 million patients worldwide ar ...
... CYP2C19 genotyping Know your patient’s response to clopidogrel before prescribing Clopidogrel decreases the likelihood of future atherothrombotic events Clopidogrel is an anti-platelet medication that requires activation by the isoenzyme Cytochrome P450 2C19. Roughly 40 million patients worldwide ar ...
erectile dysfunction
... 30 million men in the United States are estimated to have varying degrees of ED, with similar numbers in the EU. Fewer men in the EU obtain treatment compared to the Americas; cost of medications is the main barrier to care. ...
... 30 million men in the United States are estimated to have varying degrees of ED, with similar numbers in the EU. Fewer men in the EU obtain treatment compared to the Americas; cost of medications is the main barrier to care. ...
Agranulocytosis - hem
... Another mechanism is direct inhibition of myelopoiesis. Valproic acid, carbamazepine, and beta-lactam antibiotics fall into this group. In bone marrow cultures, these agents inhibit granulocyte colony formation in a dose-related ...
... Another mechanism is direct inhibition of myelopoiesis. Valproic acid, carbamazepine, and beta-lactam antibiotics fall into this group. In bone marrow cultures, these agents inhibit granulocyte colony formation in a dose-related ...
Spasticity After Stroke - UNC School of Medicine - UNC
... Hematoma and bruising are seen regardless of the site injected Local weakness, created by diffusion of Botox and is site specific Death??? ...
... Hematoma and bruising are seen regardless of the site injected Local weakness, created by diffusion of Botox and is site specific Death??? ...
pan-Canadian Oncology Drug Review Initial Clinical Guidance
... reported which included frequent infections (due to compromised immunity), shortness of breath (attributed to anemia), and easy bruising (caused by low platelet counts). LC stated that all of these symptoms can interfere with a patient’s performance, ability to work, travel and day-to-day activitie ...
... reported which included frequent infections (due to compromised immunity), shortness of breath (attributed to anemia), and easy bruising (caused by low platelet counts). LC stated that all of these symptoms can interfere with a patient’s performance, ability to work, travel and day-to-day activitie ...
Myopathies: The Effects of IVIG Therapy
... patients who received IVIG became able to walk unassisted, stopped falling and assumed household or work duties. The duration of the benefit of IVIG varied from six weeks to 12 weeks or up to a year. And, the anti-GAD antibody titers declined after IVIG, but not after a placebo.13 Of course, IVIG t ...
... patients who received IVIG became able to walk unassisted, stopped falling and assumed household or work duties. The duration of the benefit of IVIG varied from six weeks to 12 weeks or up to a year. And, the anti-GAD antibody titers declined after IVIG, but not after a placebo.13 Of course, IVIG t ...
Neuro Update Newsletter v12n4 2015 - MC5520-1015
... spinal fluid are evaluated for neural antibodies associated with the condition. Consultative comments from Mayo Clinic neurologists accompany test findings. “The panel results must be interpreted in the clinical context because there are patients with Alzheimer’s disease who have low titers of some ...
... spinal fluid are evaluated for neural antibodies associated with the condition. Consultative comments from Mayo Clinic neurologists accompany test findings. “The panel results must be interpreted in the clinical context because there are patients with Alzheimer’s disease who have low titers of some ...
Full Article
... The expression level of glucocorticoid receptor (GR) isoforms α and β might interfere with the response to exogenous glucocorticoids (GC) in different allergic disorders. No much data concerning allergic rhinitis (AR) currently exists. The aim of this study was to detect the change in the expression ...
... The expression level of glucocorticoid receptor (GR) isoforms α and β might interfere with the response to exogenous glucocorticoids (GC) in different allergic disorders. No much data concerning allergic rhinitis (AR) currently exists. The aim of this study was to detect the change in the expression ...
eMedicine - Pulmonary Embolism
... Not only are these patient groups at high risk for clinically unrecognized DVT, but half or more of the patients with DVT also can be shown to have suffered a PE, even though the majority have had none of the classic symptoms of PE. ...
... Not only are these patient groups at high risk for clinically unrecognized DVT, but half or more of the patients with DVT also can be shown to have suffered a PE, even though the majority have had none of the classic symptoms of PE. ...
Adjuvant Autologous Tumour Cell
... proliferation and production of cytotoxic clones to detect and destroy present tumour cells. In the trial presented a different vaccine was used compared to the vaccines reported Fig. 3. Progression-free survival of patients with RCC stages pT3pN0-3M0. in the literature. This fact may Probability of ...
... proliferation and production of cytotoxic clones to detect and destroy present tumour cells. In the trial presented a different vaccine was used compared to the vaccines reported Fig. 3. Progression-free survival of patients with RCC stages pT3pN0-3M0. in the literature. This fact may Probability of ...
Total Parenteral Nutrition (TPN)
... intense chemotherapy and suggest TPN is effective in repleting lean tissues of malnourished HIV patients and minimizes nutrient loss during catabolic illness. Studies show the survival rate of patients suffering from renal failure is directly related to the patient's ability to attain positive energ ...
... intense chemotherapy and suggest TPN is effective in repleting lean tissues of malnourished HIV patients and minimizes nutrient loss during catabolic illness. Studies show the survival rate of patients suffering from renal failure is directly related to the patient's ability to attain positive energ ...
Aldosteronism
... more common causes of hypertension • It often presents as hypertension and hypokalemia • It causes increased cardiovascular morbidity and mortality beyond it’s hypertension • There are many subtypes – Must diagnosis each subtype as treatment varies ...
... more common causes of hypertension • It often presents as hypertension and hypokalemia • It causes increased cardiovascular morbidity and mortality beyond it’s hypertension • There are many subtypes – Must diagnosis each subtype as treatment varies ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.